Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Yokoi

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomesMiki Nakajima, Nozomi Sakata, Noriko Ohashi, et al.
Archives of Toxicology|July 11, 2002
Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differencesMasashi Iwanari, Miki Nakajima, Ryoichi Kizu, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporterHiroshi Yamazaki, Hitomi Iketaki, Ayaka Shibata, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Surgery|December 2, 2017
Inhibition of Toll-like receptor 4 ameliorates experimental postischemic injury in the cholestatic liver through inhibition of high-mobility group box protein b1 (HMGB1) signalingTsuyoshi Yokoi, Yukihiro Yokoyama, Toshio Kokuryo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 16, 2019
Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in RatsFuhua Yang, Taiki Takeuchi, Koichi Tsuneyama, et al.
Drug Metabolism and Pharmacokinetics|February 15, 2011
Interpretation of the effects of protein kinase C inhibitors on human UDP-glucuronosyltransferase 1A (UGT1A) proteins in celluloYuko Abe, Ryoichi Fujiwara, Shingo Oda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomesMiki Nakajima, Nozomi Sakata, Noriko Ohashi, et al.
Archives of Toxicology|July 11, 2002
Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differencesMasashi Iwanari, Miki Nakajima, Ryoichi Kizu, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporterHiroshi Yamazaki, Hitomi Iketaki, Ayaka Shibata, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Surgery|December 2, 2017
Inhibition of Toll-like receptor 4 ameliorates experimental postischemic injury in the cholestatic liver through inhibition of high-mobility group box protein b1 (HMGB1) signalingTsuyoshi Yokoi, Yukihiro Yokoyama, Toshio Kokuryo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 16, 2019
Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in RatsFuhua Yang, Taiki Takeuchi, Koichi Tsuneyama, et al.
Drug Metabolism and Pharmacokinetics|February 15, 2011
Interpretation of the effects of protein kinase C inhibitors on human UDP-glucuronosyltransferase 1A (UGT1A) proteins in celluloYuko Abe, Ryoichi Fujiwara, Shingo Oda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Pageof 26